Trial Information

Multiple Sclerosis

Are you living with Multiple Sclerosis? Have you experienced a worsening of your MS symptoms or the onset of new symptoms in the last two years? If so, you may qualify for a research study.

NeuroTrials Research is conducting a 96 week, non-placebo, comparative trial to determine whether an investigational drug is more effective than a currently approved drug in patients with relapsing multiple sclerosis.

If you are between the ages of 18 and 55, have been diagnosed with multiple sclerosis and do not have a diagnosis of primary progressive MS or any other neurological disorders, you may qualify.

Qualified participants receive study related exams and study drug at no cost, and compensation for time and travel is available.

You can help keep MS research moving forward. Without volunteer participation, MS research stands still. Get moving - call 404-851-9934 or go to www.neurotrials.com.

Patient Inclusion Criteria:

Are 18-55
Have been diagnosed with MS
Have experienced either a worsening of MS symptoms or new symptoms

Patient Inclusion Criteria:

Do not have a diagnosis of primary progressive MS
Have no other neurological disorders

Neurotrials Research, Inc.
1100 Johnson Ferry Road, Suite 420
Atlanta, GA 31146
Phone: 404-851-9934
Email: info@neurotrials.com

View Map

Research Center Information: Neurotrials Research, Inc.

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.